Vimarsana
Biggest News Aggregation in the World

Immune Modulation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immune Modulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immune Modulation Today - Breaking & Trending Today

Sibeprenlimab Receives U.S. FDA Breakthrough Therapy Designation for the Treatment of Immunoglobulin A Nephropathy - Vimarsana News

Sibeprenlimab Receives U.S. FDA Breakthrough Therapy Designation for the Treatment of Immunoglobulin A Nephropathy

PRINCETON, N.J. & TOKYO & WALTHAM, Mass.--(BUSINESS WIRE)--Feb 16, 2024--

Sibeprenlimab Receives U.S. FDA Breakthrough Therapy Designation for the Treatment of Immunoglobulin - Vimarsana News

Sibeprenlimab Receives U.S. FDA Breakthrough Therapy Designation for the Treatment of Immunoglobulin

PRINCETON, N.J. & TOKYO & WALTHAM, Mass.--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc., (OPDC); Otsuka Pharmaceutical, Co. Ltd. (Otsuka); and Visterra, Inc., an Otsuka group company announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designat...

Phenomic Enters Strategic Collaboration with Boehringer Ingelheim to Discover Novel Targets for Stroma-Rich Cancer Therapies - Vimarsana News

Phenomic Enters Strategic Collaboration with Boehringer Ingelheim to Discover Novel Targets for Stroma-Rich Cancer Therapies

TORONTO & WALTHAM, Mass.--(BUSINESS WIRE)--Nov 29, 2023--

Leveraging Endoscopic Ultrasound in Pancreatic Cancer: Pancreatic Cancer Ablation and Immune Modulation - Vimarsana News

Leveraging Endoscopic Ultrasound in Pancreatic Cancer: Pancreatic Cancer Ablation and Immune Modulation

In this sixth episode of OncChats: Leveraging Endoscopic Ultrasound in Pancreatic Cancer, Toufic A. Kachaamy, MD, Madappa Kundranda, MD, PhD, and Tamas A. Gonda, MD, briefly discuss pancreatic cancer ablation and immune modulation.

STRIVE Consortium's Quest to Tame the Immune Storm - Vimarsana News

STRIVE Consortium's Quest to Tame the Immune Storm

Clinical trial to evaluate the immune modulation approach for hospitalized COVID-19 patients kicks off to investigate the potential benefits of immune modulation.